CEP72

Across TCGA pan-cancer cohorts, CEP72 RNA is linked to patient survival in 26 of 34 cancer types, making it the most broadly survival-associated CEP72 data layer compared with 3 for mutation status.

The strongest signal is observed in adrenocortical carcinoma (ACC), where higher CEP72 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated CEP72 expression acts as an unfavorable survival marker, although some lineages such as UCS and SCLC show a favorable association.

ACC, KICH, and UVM are the cancer types where CEP72 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
ACC	DFS	Median	All	0.285	0.629	<.001	145	view →
KICH	DFS	Tertile	III,IV	0.160	1.000	<.001	108	view →
UVM	DFS	Median	III,IV	0.338	0.753	<.001	81	view →
MESO	OS	Quartile	All	0.362	0.709	<.001	81	view →
LIHC	OS	Median	All	0.605	0.765	<.001	78	view →
UCS	DFS	Quartile	II,III,IV	0.704	0.224	.005	46	view →
SCLC	OS	Tertile	III,IV	0.596	0.265	.005	43	view →
UCEC	DFS	Median	All	0.793	0.878	.002	32	view →
HNSC	DFS	Median	IV	0.727	0.394	<.001	26	view →
THCA	DFS	Tertile	IV	0.409	0.848	.016	21	view →
SARC	OS	Quartile	All	0.597	0.818	.001	19	view →
THYM	OS	Quartile	II,III,IV	0.917	0.580	.009	18	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 26 lineages.

CEP72–ACC (DFS)

Open the ACC breakdown →